Shanghai SynTheAll Pharmaceutical Co., Ltd. sold 53.52 million shares of WUXI XDC (02268) at an average of HKD 73.23 per share on August 31, 2026, involving about HKD 3.92 billion.
Prior to the disposal, Shanghai SynTheAll Pharmaceutical Co., Ltd.'s long position in WUXI XDC was 232.90 million shares, representing 18.36%; following the disposal, the holding changed to 179.38 million shares, with the long position ratio falling to 14.14%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.